ofloxacin has been researched along with Acute Myelogenous Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blau, IW; Schmidt-Hieber, M; Stroux, A; Thiel, E | 1 |
| Danisovicovà, A; Krcméry, V; Mardiak, J; Minárik, T; Sajben, P; Tomásik, E; Trupl, T | 1 |
| Choi, CH; Kim, HS; Min, YD | 1 |
| Baníková, I; Faber, E; Mociková, K; Svác, J; Wildová, B | 1 |
| Aquilini, D; Bartoloni, A; Bosi, A; Fanci, R; Orsi, A; Paradisi, F; Rossi Ferrini, P | 1 |
3 trial(s) available for ofloxacin and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Antibacterial prophylaxis with levofloxacin in patients after allogeneic stem cell transplantation and neutrophil reconstitution: results from a double-blinded, placebo-controlled phase III trial and overview of recent clinical practice.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Double-Blind Method; Female; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Ofloxacin; Placebos; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2010 |
Fluconazol plus ofloxacin in prophylaxis of infections in patients with acute leukemia: a comparative study.
Topics: Adult; Bacterial Infections; Drug Costs; Drug Therapy, Combination; Female; Fluconazole; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Ofloxacin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Time Factors | 1993 |
The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects.
Topics: Adult; Aged; Agranulocytosis; Bacteria, Aerobic; Drug Combinations; Female; Humans; Intestines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Ofloxacin; Random Allocation; Sulfamethizole; Sulfathiazoles; Trimethoprim | 1989 |
2 other study(ies) available for ofloxacin and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Erythromycin; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Ofloxacin; Probenecid; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Tumor Cells, Cultured; Uricosuric Agents; Vincristine | 2001 |
[Comparison of Tarivid and Biseptol in the prevention of bacterial infections in patients with acute leukemia].
Topics: Bacterial Infections; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Ofloxacin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |